Anal Cancer Market is expected to witness significant growth over the forecast period. The market was valued at approximately USD 673.92 million in 2018 and is projected to register a 6.46% CAGR over the forecast period.
Anal cancer is a rare type of malignancy that starts in the anus, which is the opening at the end of the rectum.
Factors such as the rising prevalence of anal cancer and the growing number of sexually transmitted diseases are expected to drive market growth. According to an article published by the American Cancer Society, an estimated 8,300 new cases of anal cancer will be diagnosed in 2019. Moreover, increasing research and development expenditure in the field of oncology is also expected to boost market growth.
However, the side effects of the treatment and lack of awareness are expected to hamper the market growth.
Segmentation
The global anal cancer market has been segmented into cancer type, treatment type, end user, and region.
Based on cancer type, the global anal cancer market has been segmented into carcinoma in situ, squamous cell carcinoma, melanoma, adenocarcinoma, basal cell carcinoma, and others.
The global anal cancer market, by treatment type, has been segmented into chemotherapy, surgery, radiation therapy, and immunotherapy.
The global anal cancer market, by end user, has been segmented into hospitals & clinics, research & academic institutes, and others.
Key Players
Amgen Inc. (US), Bristol-Myers Squibb Company (US), Celgene Corporation (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Merck & Co., Inc. (US), Novartis AG (Switzerland), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Sanofi (France), Johnson & Johnson Services, Inc. (US) and Hospira, Inc. (US) are some of the key players operating in the global anal cancer market.
Global Anal Cancer Market, by Cancer Type
- Carcinoma in Situ
- Squamous Cell Carcinoma
- Adenocarcinoma
- Basal Cell Carcinoma
- Melanoma
- Others
Global Anal Cancer Market, by Treatment Type
- Chemotherapy
- Surgery
- Radiation Therapy
- Immunotherapy
Global Anal Cancer Market, by End User
- Hospitals and Clinics
- Research and Academic Institutes
- Others
Request Customization
Get a Sample
Get a Sample
Request Customization